| |
| |
|
| Insider
Information: |
Smith David Ross |
| Relationship: |
Corporate Executive VP... |
| City: |
Wilmington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
25,819 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,074,436 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
25,819 |
|
|
| Total
Value |
$6,074,436 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 101.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Charles River Laboratories Inter... |
CRL |
Corporate Executive VP... |
2022-03-03 |
25,819 |
2021-02-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2022-03-03 |
4 |
OE |
$109.34 |
$1,224,594 |
D/D |
8,965 |
34,784 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2022-03-03 |
4 |
S |
$281.49 |
$2,532,921 |
D/D |
(8,965) |
25,819 |
0 |
% |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
5,152 |
25,819 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2022-02-23 |
4 |
D |
$289.58 |
$108,303 |
D/D |
(374) |
20,667 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2022-02-22 |
4 |
D |
$293.61 |
$100,121 |
D/D |
(341) |
21,041 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2022-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
12,321 |
26,746 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2022-01-28 |
4 |
D |
$312.24 |
$1,674,855 |
D/D |
(5,364) |
21,382 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2021-08-09 |
4 |
S |
$406.36 |
$712,954 |
D/D |
(1,750) |
14,425 |
0 |
% |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2021-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,313 |
16,175 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2021-05-04 |
4 |
OE |
$144.67 |
$478,134 |
D/D |
3,305 |
18,167 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2021-05-04 |
4 |
AS |
$340.01 |
$1,123,718 |
D/D |
(3,305) |
14,862 |
0 |
% |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2021-04-22 |
4 |
AS |
$330.00 |
$1,268,850 |
D/D |
(3,845) |
14,862 |
0 |
% |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2021-04-22 |
4 |
OE |
$109.34 |
$420,412 |
D/D |
3,845 |
18,707 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2021-04-15 |
4 |
AS |
$320.00 |
$640,000 |
D/D |
(2,000) |
14,862 |
0 |
% |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2021-03-01 |
4 |
OE |
$88.05 |
$384,426 |
D/D |
4,366 |
21,228 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2021-03-01 |
4 |
S |
$290.12 |
$1,266,647 |
D/D |
(4,366) |
16,862 |
0 |
% |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2021-02-24 |
4 |
D |
$282.98 |
$81,781 |
D/D |
(289) |
16,862 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2021-02-23 |
4/A |
D |
$283.59 |
$68,629 |
D/D |
(242) |
17,151 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2021-02-23 |
4 |
D |
$283.59 |
$77,136 |
D/D |
(272) |
17,031 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2021-02-22 |
4 |
D |
$289.55 |
$71,519 |
D/D |
(247) |
17,303 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2021-02-22 |
4/A |
D |
$289.55 |
$45,459 |
D/D |
(157) |
17,393 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2021-02-19 |
4 |
S |
$290.03 |
$2,515,686 |
I/I |
(8,656) |
0 |
0 |
% |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2021-01-29 |
4 |
D |
$260.88 |
$990,040 |
D/D |
(3,795) |
17,550 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
14,234 |
21,345 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & CFO |
• • – |
2021-01-25 |
4 |
GA |
$0.00 |
$0 |
I/I |
8,656 |
8,656 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
